Cargando…

Radiolabeling of Nanoparticles and Polymers for PET Imaging

Nanomedicine has become an emerging field in imaging and therapy of malignancies. Nanodimensional drug delivery systems have already been used in the clinic, as carriers for sensitive chemotherapeutics or highly toxic substances. In addition, those nanodimensional structures are further able to carr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stockhofe, Katharina, Postema, Johannes M., Schieferstein, Hanno, Ross, Tobias L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014699/ https://www.ncbi.nlm.nih.gov/pubmed/24699244 http://dx.doi.org/10.3390/ph7040392

Ejemplares similares

Radiolabeled PET/MRI Nanoparticles for Tumor Imaging
por: Forte, Ernesto, et al.
Publicado: (2019)

(18) F-click labeling and preclinical evaluation of a new (18) F-folate for PET imaging
por: Schieferstein, Hanno, et al.
Publicado: (2013)

Radiolabelling of Extracellular Vesicles for PET and SPECT imaging
por: Khan, Azalea A., et al.
Publicado: (2021)

Methods for Radiolabelling Nanoparticles: PET Use (Part 2)
por: Bentivoglio, Valeria, et al.
Publicado: (2022)

Radiolabeled Nanoparticles for Multimodality Tumor Imaging
por: Xing, Yan, et al.
Publicado: (2014)

(18)F-Labeling Using Click Cycloadditions
por: Kettenbach, Kathrin, et al.
Publicado: (2014)

Radiolabeled Gold Nanoparticles for Imaging and Therapy of Cancer
por: Silva, Francisco, et al.
Publicado: (2020)

Radiolabeled Small Molecule Protein Kinase Inhibitors for Imaging with PET or SPECT
por: Hicks, Justin W., et al.
Publicado: (2010)

Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2015)

Chelator-Free Radiolabeling of SERRS Nanoparticles for Whole-Body PET and Intraoperative Raman Imaging
por: Wall, Matthew A., et al.
Publicado: (2017)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
por: van Dongen, Guus A. M. S., et al.
Publicado: (2012)

Radiolabeled Iron Oxide Nanoparticles as Dual Modality Contrast Agents in SPECT/MRI and PET/MRI
por: Karageorgou, Maria-Argyro, et al.
Publicado: (2023)

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
por: Sardana, Malvika, et al.
Publicado: (2022)

Radiolabeled theranostics: magnetic and gold nanoparticles
por: Same, Saeideh, et al.
Publicado: (2016)

Preclinical Evaluation of Radiolabeled Peptides for PET Imaging of Glioblastoma Multiforme
por: Novy, Zbynek, et al.
Publicado: (2019)

Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging
por: Gawne, Peter J., et al.
Publicado: (2022)

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)

Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin α(v)β(3)
por: Chen, Haojun, et al.
Publicado: (2016)

In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
por: Stephens, Ross W., et al.
Publicado: (2021)

Radiolabeled Antibodies for Cancer Imaging and Therapy
por: Parakh, Sagun, et al.
Publicado: (2022)

Radiolabeled Silicon-Rhodamines as Bimodal PET/SPECT-NIR Imaging Agents
por: Kanagasundaram, Thines, et al.
Publicado: (2021)

Mechanoporation enables rapid and efficient radiolabeling of stem cells for PET imaging
por: Jung, Kyung Oh, et al.
Publicado: (2022)

Evaluation of (68)Ga-Radiolabeled Peptides for HER2 PET Imaging
por: Ducharme, Maxwell, et al.
Publicado: (2022)

Radiolabeling Strategies of Nanobodies for Imaging Applications
por: Küppers, Jim, et al.
Publicado: (2021)

Radiolabeled Liposomes for Nuclear Imaging Probes
por: Low, Ho Ying, et al.
Publicado: (2023)

Radiolabeled Dendrimer Coated Nanoparticles for Radionuclide Imaging and Therapy: A Systematic Review
por: Conte, Miriam, et al.
Publicado: (2023)

Isotopic Radiolabeling of the Antiretroviral Drug [(18)F]Dolutegravir for Pharmacokinetic PET Imaging
por: Tisseraud, Marion, et al.
Publicado: (2022)

Emerging role of radiolabeled nanoparticles as an effective diagnostic technique
por: de Barros, AndréLuís Branco, et al.
Publicado: (2012)

Methods for Radiolabelling Nanoparticles: SPECT Use (Part 1)
por: Varani, Michela, et al.
Publicado: (2022)

Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
por: Fu, Ruisi, et al.
Publicado: (2018)

Biodistribution of (68/67)Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging
por: Díez-Villares, Sandra, et al.
Publicado: (2021)

Synthesis, Fluorine-18 Radiolabeling, and In Vivo PET Imaging of a Hydrophilic Fluorosulfotetrazine
por: Beaufrez, Jason, et al.
Publicado: (2023)

Molecular imaging of hypoxia with radiolabelled agents
por: Mees, Gilles, et al.
Publicado: (2009)

Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
por: Chrastina, Adrian, et al.
Publicado: (2010)

Authentically radiolabelled Mn(II) complexes as bimodal PET/MR tracers
por: Vanasschen, Christian, et al.
Publicado: (2015)

Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma
por: Schmitt, Julia, et al.
Publicado: (2022)

Methods for Radiolabeling Nanoparticles (Part 3): Therapeutic Use
por: Bentivoglio, Valeria, et al.
Publicado: (2023)

New perspectives on metabolic imaging in the management of prostate cancer in 2022: A focus on radiolabeled PSMA‑PET/CT (Review)
por: Simon, Hélène, et al.
Publicado: (2023)

Radio-enhancement effects by radiolabeled nanoparticles
por: Gholami, Yaser Hadi, et al.
Publicado: (2019)

Pharmacokinetic properties of radiolabeled mutant Interleukin-2v: a PET imaging study
por: Hartimath, Siddesh V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0j9djmdfsoiqknp6s5gr2f93fl